CY1113335T1 - Παραγωγο ν-φαινυλ-(2r,5s)διμεθυλπιπεραζινης - Google Patents
Παραγωγο ν-φαινυλ-(2r,5s)διμεθυλπιπεραζινηςInfo
- Publication number
- CY1113335T1 CY1113335T1 CY20121101108T CY121101108T CY1113335T1 CY 1113335 T1 CY1113335 T1 CY 1113335T1 CY 20121101108 T CY20121101108 T CY 20121101108T CY 121101108 T CY121101108 T CY 121101108T CY 1113335 T1 CY1113335 T1 CY 1113335T1
- Authority
- CY
- Cyprus
- Prior art keywords
- dimethylpiperazine
- useful
- fenyl
- product
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002203690 | 2002-07-12 | ||
| EP03764179A EP1557411B1 (en) | 2002-07-12 | 2003-07-11 | N-phenyl-(2r,5s)dimethylpiperazine derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1113335T1 true CY1113335T1 (el) | 2016-06-22 |
Family
ID=30112682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20121101108T CY1113335T1 (el) | 2002-07-12 | 2012-11-19 | Παραγωγο ν-φαινυλ-(2r,5s)διμεθυλπιπεραζινης |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7297698B2 (enExample) |
| EP (1) | EP1557411B1 (enExample) |
| JP (1) | JP4449746B2 (enExample) |
| AU (1) | AU2003248052A1 (enExample) |
| CA (1) | CA2492138C (enExample) |
| CY (1) | CY1113335T1 (enExample) |
| DK (1) | DK1557411T3 (enExample) |
| ES (1) | ES2393333T3 (enExample) |
| PT (1) | PT1557411E (enExample) |
| SI (1) | SI1557411T1 (enExample) |
| WO (1) | WO2004007471A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7879328B2 (en) * | 2000-06-16 | 2011-02-01 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to B lymphocyte stimulator |
| ATE450533T1 (de) * | 2003-02-14 | 2009-12-15 | Glaxo Group Ltd | Carboxamidderivate |
| CA2535416A1 (en) * | 2003-08-15 | 2005-02-24 | Banyu Pharmaceutical Co., Ltd. | Imidazopyridine derivatives |
| WO2005108399A1 (ja) * | 2004-05-10 | 2005-11-17 | Banyu Pharmaceutical Co., Ltd. | イミダゾピリジン化合物 |
| TW200628446A (en) * | 2004-12-14 | 2006-08-16 | Takeda Pharmaceuticals Co | Substituted pyrrole derivative |
| MX2009000508A (es) * | 2006-07-14 | 2009-01-27 | Pfizer Prod Inc | Sal tartrato de (7s)-7-[(5-fluoro-2-metil-bencil)oxi]-2-[(2r)-2-me tilpiperazin-1-il]-6,7-dihidro-5h-ciclopenta[b]piridina. |
| BRPI0907844B8 (pt) * | 2008-02-22 | 2021-05-25 | Radius Health Inc | compostos e método para modular um receptor de andrógeno, processos de preparação e composição farmacêutica dos mesmos e seus usos |
| US8268872B2 (en) | 2008-02-22 | 2012-09-18 | Radius Health, Inc. | Selective androgen receptor modulators |
| CN102548991B (zh) | 2009-09-24 | 2015-03-25 | 霍夫曼-拉罗奇有限公司 | 作为磷酸二酯酶10a抑制剂的咪唑并吡啶或咪唑并嘧啶衍生物 |
| JP5964756B2 (ja) | 2010-02-04 | 2016-08-03 | ラジウス ヘルス，インコーポレイテッド | 選択的アンドロゲン受容体モジュレーター |
| EP2539706B1 (en) * | 2010-02-24 | 2015-03-04 | Research Triangle Institute | Arylpiperazine opioid receptor antagonists |
| DK2568806T3 (en) | 2010-05-12 | 2016-08-15 | Radius Health Inc | therapy Programs |
| US8642632B2 (en) | 2010-07-02 | 2014-02-04 | Radius Health, Inc. | Selective androgen receptor modulators |
| EP2621901B1 (en) | 2010-09-28 | 2015-07-29 | Radius Health, Inc | Selective androgen receptor modulators |
| TW201305130A (zh) * | 2010-10-22 | 2013-02-01 | Astellas Pharma Inc | 突變雄激素受體拮抗藥 |
| WO2013058361A1 (ja) | 2011-10-21 | 2013-04-25 | アステラス製薬株式会社 | アンドロゲン受容体拮抗化合物の結晶 |
| US8765767B2 (en) * | 2012-03-16 | 2014-07-01 | Bristol-Myers Squibb Company | Positive allosteric modulators of mGluR2 |
| PL3231800T3 (pl) * | 2014-12-08 | 2020-04-30 | Lsk Nrdo Co., Ltd. | Nowa pochodna 4-(arylo) -n-(2-alkoksytieno[3,2-b]pirazyn-3-ylo)-piperazyno-1-karboksyamidu oraz jej działanie antyproliferacyjne |
| WO2016196955A1 (en) | 2015-06-04 | 2016-12-08 | Drexel University | Inhibitors of RAD52 Recombination Protein and Methods Using Same |
| CN105130847A (zh) * | 2015-09-10 | 2015-12-09 | 成都大学 | 一种制备高纯邻甲基苯腈及其衍生物的方法 |
| SG11201811225RA (en) | 2016-06-22 | 2019-01-30 | Radius Health Inc | Ar+ breast cancer treatment methods |
| SG11202009388XA (en) | 2018-03-26 | 2020-10-29 | Basf Se | Novel hyperbranched polyesters and their use as wax inhibitor, as pour point depressant, as lubricant or in lubricating oils |
| EP4034114A4 (en) * | 2019-09-23 | 2023-07-26 | Accutar Biotechnology Inc. | NEW UREAES HAVING ANDROGEN RECEPTOR DEGRADING ACTIVITY AND THEIR USES |
| AU2022333206A1 (en) | 2021-08-27 | 2024-04-11 | Basf Se | Aqueous dispersions of paraffin inhibitors |
| AU2022336800A1 (en) | 2021-08-30 | 2024-04-11 | Basf Se | Hyperbranched polyesters modified with branched fatty acids and their use as paraffin inhibitors |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3875229A (en) | 1972-11-24 | 1975-04-01 | Schering Corp | Substituted carboxanilides |
| EP0100172B1 (en) | 1982-07-23 | 1987-08-12 | Imperial Chemical Industries Plc | Amide derivatives |
| US4694004A (en) * | 1984-07-09 | 1987-09-15 | Fujisawa Pharmaceutical Co., Ltd. | Semicarbazide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same |
| CA2181358A1 (en) | 1994-01-21 | 1995-07-27 | Nancy M. Gray | Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex |
| BR9914018A (pt) * | 1998-09-22 | 2001-07-03 | Yamanouchi Pharmaceuticals Co | Derivado de cianofenila |
| JP2001328938A (ja) * | 2000-03-17 | 2001-11-27 | Yamanouchi Pharmaceut Co Ltd | シアノフェニル誘導体を有効成分とする医薬 |
| US20030236287A1 (en) * | 2002-05-03 | 2003-12-25 | Piotrowski David W. | Positive allosteric modulators of the nicotinic acetylcholine receptor |
-
2003
- 2003-07-11 DK DK03764179.2T patent/DK1557411T3/da active
- 2003-07-11 AU AU2003248052A patent/AU2003248052A1/en not_active Abandoned
- 2003-07-11 EP EP03764179A patent/EP1557411B1/en not_active Expired - Lifetime
- 2003-07-11 ES ES03764179T patent/ES2393333T3/es not_active Expired - Lifetime
- 2003-07-11 US US10/521,119 patent/US7297698B2/en not_active Expired - Lifetime
- 2003-07-11 WO PCT/JP2003/008860 patent/WO2004007471A1/ja not_active Ceased
- 2003-07-11 PT PT03764179T patent/PT1557411E/pt unknown
- 2003-07-11 JP JP2004521198A patent/JP4449746B2/ja not_active Expired - Fee Related
- 2003-07-11 SI SI200332218T patent/SI1557411T1/sl unknown
- 2003-07-11 CA CA2492138A patent/CA2492138C/en not_active Expired - Fee Related
-
2007
- 2007-09-26 US US11/861,327 patent/US7666873B2/en not_active Expired - Fee Related
-
2012
- 2012-11-19 CY CY20121101108T patent/CY1113335T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP4449746B2 (ja) | 2010-04-14 |
| US20050261303A1 (en) | 2005-11-24 |
| US7666873B2 (en) | 2010-02-23 |
| CA2492138C (en) | 2011-01-11 |
| WO2004007471A1 (ja) | 2004-01-22 |
| ES2393333T3 (es) | 2012-12-20 |
| JPWO2004007471A1 (ja) | 2005-11-17 |
| AU2003248052A1 (en) | 2004-02-02 |
| US7297698B2 (en) | 2007-11-20 |
| EP1557411A1 (en) | 2005-07-27 |
| EP1557411B1 (en) | 2012-10-17 |
| CA2492138A1 (en) | 2004-01-22 |
| EP1557411A4 (en) | 2011-02-23 |
| SI1557411T1 (enExample) | 2013-01-31 |
| DK1557411T3 (da) | 2012-11-05 |
| US20080214543A1 (en) | 2008-09-04 |
| PT1557411E (pt) | 2012-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1113335T1 (el) | Παραγωγο ν-φαινυλ-(2r,5s)διμεθυλπιπεραζινης | |
| CY1118480T1 (el) | Παραγωγα toy uk-2a | |
| TR200200118T2 (tr) | Yeni bileşimler | |
| CY1115782T1 (el) | Φαρμακευτικες συνθεσεις για θεραπεια καρκινου | |
| ECSP034568A (es) | Inhibidores de metaloproteinasa del tipo pirimidin 2,4,6-triona | |
| CY1107637T1 (el) | Θεραπευτικη αγωγη καρκινου προστατη με αντισωματα αντι - erbb2 | |
| CY1121043T1 (el) | Θεραπευτικες ενωσεις | |
| CY1113538T1 (el) | Παραγωγα της 5-αμινο-2,4,7-τριοξο-3,4,7,8-τετραϋδρο-2η-πυριδο[2,3-d] πυριμιδινης και παρομοιες ενωσεις για την αγωγη του καρκινου | |
| PA8571001A1 (es) | 2-(2,6-diclorofenil)-diarilimidazoles | |
| DE50310516D1 (de) | Fredericamycin-derivate | |
| CY1112946T1 (el) | 4-υδροξυβενζομορφανια | |
| HN2001000244A (es) | Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas. | |
| DE69942827D1 (de) | Verwendung der epothilons zur behandlung der krebs | |
| BRPI0510177B8 (pt) | composto, composição farmacêutica e uso do mesmo | |
| BR0308787A (pt) | Inibidores de metaloproteinase de n-substituìdos-heteroarilóxi-aril-espiro-pirimidina- 2,4,6-triona | |
| CY1108416T1 (el) | Ενωσεις για την αγωγη του αλγους | |
| CY1113813T1 (el) | Νεες ενωσεις που εχουν ανασταλτικη δραστικοτητα εναντια στον εξαρτωμενο απο το νατριο μεταφορεα | |
| BR112021025699A2 (pt) | Anticorpos anti-mesotelina e imunoconjugados dos mesmos | |
| ATE362758T1 (de) | Indomethacin-amidderivate zur antiangiogenen und/oder antitumorigen verwendung | |
| BR0308606A (pt) | Derivados de hemiasterlina e usos destes | |
| PT1390371E (pt) | Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores | |
| CY1105803T1 (el) | Συνθεση πepιλαμβανουσα καμπτοθεκινη και ενα παραγωγο πυριμιδινης για τη θepαπεια καρκινου | |
| NI200300045A (es) | Inhibidores de triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa. | |
| EP1667685A4 (en) | -QUINAZOLINE-POTASSIUM CHANNEL INHIBITORS | |
| NO20015338D0 (no) | Androgenderivater og anvendelse derav |